Cleveland Clinic Cancer Advances

Ruth Keri, PhD, Associate Director for Basic Research at the Case Comprehensive Cancer Center and Professor of Cancer Biology at Cleveland Clinic, joins the Cancer Advances Podcast to talk about her research on a promising new target for treating triple-negative breast cancer, YES1 inhibitors. Listen as Dr. Keri shares the potential of YES1 inhibitors in improving the effectiveness of chemotherapy...

Suneel Kamath, MD, a hematologist and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss his research from the American Society of Clinical Oncology (ASCO) 2023 annual meeting on the metabolomic differences between young onset colorectal cancer (yoCRC) and average onset colorectal cancer (aoCRC). Listen as Dr. Kamath talks about the challenges associ...

We kick off Breast Cancer Awareness Month with radiologist Laura Dean, MD, who discusses the incorporation of artificial intelligence (AI) into mammography for breast cancer screening and detection. Listen in as our host, Dr. Dale Shepard, talks with Dr. Dean about the new AI algorithms that have improved the accuracy of mammogram interpretations. Dr. Dean explains digital breast tomosynthesis (3D...

Omar Mian, MD, PhD, radiation oncologist, and physician scientist, joins the Cancer Advances Podcast to talk about emerging molecular biomarkers for genitourinary cancers. During the episode, Dr. Mian explains the multidisciplinary approach required for effective biomarker utilization, the success of prognostic and predictive biomarkers, and his ongoing research on germline polymorphisms and the u...

Urologic Oncologist, Zeyad Schwen, MD, joins the Cancer Advances podcast to discuss focal therapies for prostate cancer. Dr. Schwen provides insights into the selection process for candidates and explores various focal therapy methods like NanoKnife and HIFU (High-Intensity Focused Ultrasound). Listen as Dr. Schwen explains the benefits, limitations, and ongoing clinical trials of these treatments...

Director of the Novel Cancer Therapeutics Center, Wen Wee Ma, MBBS, joins the Cancer Advances podcast to talk about the Novel Cancer Therapeutics Center. Listen as Dr. Ma delves into the center's mission and role to help bring the latest innovative treatments to patients, expanding clinical trial accessibility across different regions, and the shift from traditional drug-focused approaches to...

The Cancer Advances podcast kicks off Prostate Cancer Awareness Month with urologic oncologist Zeyad Schwen, MD, to talk about active surveillance. Listen as Dr. Schwen explains the history of prostate cancer diagnosis, the importance of accurate risk assessment to prevent overtreatment, the significance of PSA testing, and the evolving role of advanced imaging techniques.

The Cancer Advances podcast is joined by Justin Lathia, PhD, Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Research, Scientific Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, and the Vice Chair of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute to talk about his study on mitochondria transfer for gliobl...

Mr. Stewart Kohl, co-CEO of the Riverside Company, a member of the board of directors at Cleveland Clinic, and founder of VeloSano joins the Cancer Advances podcast to celebrate 10 years of Cleveland Clinic's cancer research fundraising initiative, VeloSano. Listen as Mr. Kohl talks about the journey of VeloSano's 10-year impact on advancing cancer research.

In this episode of Cancer Advances, host Dale Shepard, MD, PhD, talks with Tatiana Byzova, PhD, a staff member in the neurosciences program, about the significance of thrombosis in cancer patients along with current therapy options. Listen as they discuss the challenges of balancing anticoagulant therapy, and Dr. Byzova's research on tumor-platelet interactions and the role of vesicles in thr...

Gary Schwartz, MD, Director of the Case Comprehensive Cancer Center, and a medical oncologist who specializes in sarcoma joins the Cancer Advances podcast to discuss his goal of improving cancer care not just in Cleveland, but beyond. Listen as he talks about his vision for seamless integration of science and clinical practice and fostering rapid translation from bench to bedside and more.

In this episode of the Cancer Advances podcast, Dale Shepard, MD, PhD is joined by Shlomo Koyfman, MD, Director of Head and Neck and Skin Radiation at Cleveland Clinic to discuss the use of stereotactic body radiation therapy (SBRT) for head and neck cancer treatment. Dr. Koyfman shares insights from his experience highlighting the role of SBRT in re-irradiation cases as a primary therapy option....

Zachary D. Burke, MD, an orthopedic oncologist specializing in pediatric sarcomas, joins the Cancer Advances Podcast to talk about limb sparing surgical techniques for pediatric sarcoma. Listen as Dr. Burke explains the unique challenges posed by pediatric cases, the advancements being made in the field, and research efforts aimed at improving sarcoma treatments.

Arun D. Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, joins the Cancer Advances podcast to discuss metastases to the eye. Listen as Dr. Singh talks about the common types of cancer that metastasize to the eye, symptoms, treatment options, and the importance of looking out for metastases in patients.

Adriana Alveraz, MD, regional oncologist and palliative medicine physician, joins the Cancer Advances Podcast to talk about cancer-related anorexia and cachexia syndrome. Listen as Dr. Alveraz explains the challenges in diagnosing this syndrome, what physicians should pay attention to, as well as the importance of palliative care with cancer treatment.

Joseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute, and Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute, specializing in head and neck cancers, join the Cancer Advances podcast to discuss their study that provides insights to treatment strategies and tumor characteristics of anaplastic thyroid c...

Lukas Nystrom, MD, an orthopedic surgeon at Cleveland Clinic specializing in musculoskeletal oncology, joins the Cancer Advances podcast to talk about the management of soft tissue sarcoma in adults. Listen as Dr. Nystrom talks about the misconceptions and the multidisciplinary care that is needed to treat this rare cancer.

Jack Khouri, MD, hematologist oncologist at Cleveland Clinic Cancer Center, who specializes in rare plasma cell disorders joins the Cancer Advances podcast to discuss ide-CEL CAR T-cell therapy and its effectiveness in multiple myeloma patients. Listen as Dr. Khouri talks about the KarMMA trial and his retrospective study.

Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.

Radiation Oncologist, Physician Scientist, and Founding Director of the Center for Hyperthermia at Cleveland Clinic, Jennifer Yu, MD, PhD, joins the Cancer Advances podcast to discuss hyperthermia therapy, which uses heat to destroy cancer cells and shrink tumors. Listen as Dr. Yu explains how this therapy works; and how it helps radiation and chemotherapy treatments become more effective for pati...

The Cancer Advances podcast is joined by Abhay Singh, MD, MPH, a physician with the Department of Hematology and Medical Oncology at Cleveland Clinic to talk about his study, which aimed to identify risk factors for secondary malignancy in breast cancer survivors. This study was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Singh explains how he explored...

Alex A. Adjei, MD, PhD, Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to discuss the new Novel Therapeutics Clinic. Listen as Dr. Adjei shares the importance of novel cancer therapetuics, how the clinic is structured, and his hopes of having multiple treatment options for every cancer.

Arun D. Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, and Stacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's join the Cancer Advances podcast to discuss retinoblastoma. Listen as they discuss this unique children's eye cancer, the treatment options available, and the genetic counseling we have at Cleveland Clinic.

Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute specializing in head and neck cancers, joins the Cancer Advances podcast to discuss new ASCO guidelines for recurrent and metastatic head and neck cancers. Listen as Dr. Yilmaz explains how the guidelines focus on biomarkers, tumor mutation burdens, and how they will impact patient care.

Aaron Gerds, MD, MS, a hematologist in Cleveland Clinic Cancer Center’s Leukemia and Myeloid Disorders Program and Deputy Director for Clinical Research at the Taussig Cancer Institute joins the Cancer Advances podcast to talk about the MOMENTUM trial that was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Gerds discusses myelofibrosis, the differences bet...